Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas-Reference-Cited by-同舟云学术

Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas

Published:2021-12 Issue:4 Volume:1 Page:153-162
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Zhong Jia,Li Xiaoting,Wang Zhijie,Duan Jianchun,Li Wenbin,Zhuo Minglei,An Tongtong,Wang Ziping,Gu Tiantian,Wang Yuyan,Bai Hua,Wang Yan,Wu Meina,Zhao Zhikun,Yang Xin,Su Zhe,Zhu Xiang,Wan Rui,Li Jianjie,Zhao Jie,Chang Geyun,Yang Xue,Chen Hanxiao,Xue Liying,Shi Xiaohua,Zhao Jun,Wang Jie^ORCID

Publisher

Elsevier BV

Reference43 articles.

1. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras;Jackson;Genes Dev,2001

2. Modeling human lung cancer in mice: similarities and shortcomings;Tuveson;Oncogene,1999

3. The 2015 World Health Organization Classification of lung tumors: new entities since the 2004 Classification;Mengoli;Pathologica.,2018

4. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer;Calbo;Cancer Cell,2011

5. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features;Finberg;J Mol Diagn,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotyping of RB1 status identifies two distinct subtypes in EGFR‐mutant lung cancers with SCLC transformation;Clinical and Translational Medicine;2024-05

2. Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study;Clinical Oncology;2024-01

3. APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during acquired resistance to EGFR inhibitors in lung cancer;2023-07-03

4. Lobetyolin suppressed lung cancer in a mouse model by inhibiting epithelial-mesenchymal transition;European Journal of Histochemistry;2022-07-04